Article Information
History
- October 11, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marika Watanabe1,†,
- Kimikazu Yakushijin1,†,*,
- Yohei Funakoshi1,†,
- Goh Ohji2,
- Hiroya Ichikawa1,
- Hironori Sakai3,
- Wataru Hojo3,
- Miki Saeki1,
- Yuri Hirakawa1,
- Sakuya Matsumoto1,
- Rina Sakai1,
- Shigeki Nagao1,
- Akihito Kitao1,
- Yoshiharu Miyata4,
- Taiji Koyama1,
- Yasuyuki Saito5,
- Shinichiro Kawamoto1,
- Katsuya Yamamoto1,
- Mitsuhiro Ito1,6,
- Tohru Murayama1,7,
- Hiroshi Matsuoka4 and
- Hironobu Minami1,8
- 1Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan
- 2Division of Infectious Disease Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan
- 3R&D, Cellspect Co., Ltd., Morioka, Iwate, Japan
- 4BioResource Center, Kobe University Hospital, Kobe, Japan
- 5Division of Molecular and Cellular Signaling, Kobe University Graduate School of Medicine, Kobe, Japan
- 6Laboratory of Hematology, Division of Medical Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan
- 7Department of Hematology, Hyogo Cancer Center, Akashi, Japan
- 8Cancer Center, Kobe University Hospital, Kobe, Japan
- ↵*Correspondence: kyakushi{at}med.kobe-u.ac.jp, TEL +81-78-382-5820, FAX +81-78-382-5821
↵† These authors contributed equally to this work.
Posted October 11, 2022.
A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients
